Notify me when Rachel E. Haurwitz files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CRBU | Caribou Biosciences, Inc. | Common stock, par value $0.0001 per share | 5% | $4,008,603 | 4,716,003 | Rachel E. Haurwitz | 22 Apr 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|